The mouse retina as an angiogenesis model.

The mouse retina has been used extensively over the past decades to study both physiologic and pathologic angiogenesis. Over time, various mouse retina models have evolved into well-characterized and robust tools for in vivo angiogenesis research. This article is a review of the angiogenic development of the mouse retina and a discussion of some of the most widely used vascular disease models. From the multitude of studies performed in the mouse retina, a selection of representative works is discussed in more detail regarding their role in advancing the understanding of both the ocular and general mechanisms of angiogenesis.

[1]  J. Heckenlively,et al.  Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. , 2004, The Journal of clinical investigation.

[2]  K. Yu,et al.  Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. , 1999, Current eye research.

[3]  T. Gardner,et al.  Retinal angiogenesis in development and disease , 2005, Nature.

[4]  Eiji Sakurai,et al.  An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.

[5]  R. D'Amato,et al.  Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. , 1993, Microvascular research.

[6]  N. Sengupta,et al.  Preventing stem cell incorporation into choroidal neovascularization by targeting homing and attachment factors. , 2005, Investigative ophthalmology & visual science.

[7]  J. Stone,et al.  Role of astrocytes in the control of developing retinal vessels. , 1997, Investigative ophthalmology & visual science.

[8]  H. Hammes,et al.  Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression , 2006, Thrombosis and Haemostasis.

[9]  E. Ayuso,et al.  Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. , 2004, The Journal of clinical investigation.

[10]  Joan W. Miller,et al.  Review of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy , 2009, Seminars in ophthalmology.

[11]  M. Trese,et al.  Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. , 2004, American journal of human genetics.

[12]  Y. Ogura,et al.  Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease , 2003, Nature Medicine.

[13]  L. Gyllensten,et al.  Experimental Approach to the Pathogenesis of Retrolental Fibroplasia: I. Changes of the Eye Induced by Exposure of Newborn Mice to Concentrated Oxygen , 1954, Acta paediatrica. Supplementum.

[14]  A. Barber,et al.  Retinal ganglion cells in diabetes , 2008, Journal of Physiology.

[15]  M. Repka,et al.  Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. , 2000, Archives of ophthalmology.

[16]  Joan W. Miller,et al.  Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. , 2009, Investigative ophthalmology & visual science.

[17]  Lois E. H. Smith,et al.  Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Lois E. H. Smith,et al.  A Pharmacokinetic and Dosing Study of Intravenous Insulin-Like Growth Factor-I and IGF-Binding Protein-3 Complex to Preterm Infants , 2009, Pediatric Research.

[19]  Michael J Parker,et al.  Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. , 2004, American journal of human genetics.

[20]  D. Anthony,et al.  Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. , 1997, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[21]  M. Bartoli,et al.  Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. , 2002, Investigative ophthalmology & visual science.

[22]  Ulrich Schraermeyer,et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  W. Risau,et al.  Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: A role for vascular endothelial growth factor as a survival factor for endothelium , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  A. Bird,et al.  Progenitor cells and retinal angiogenesis , 2007, Angiogenesis.

[25]  Joan W. Miller,et al.  Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[26]  T. Kern,et al.  A mouse model of diabetic retinopathy. , 1996, Archives of ophthalmology.

[27]  Alan W. Stitt,et al.  Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. , 2005, The American journal of pathology.

[28]  Y. Fujii‐Kuriyama,et al.  HLF/HIF‐2α is a key factor in retinopathy of prematurity in association with erythropoietin , 2003, The EMBO journal.

[29]  R. Frank.  Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. , 1997, Ophthalmic research.

[30]  A. Madan,et al.  Animal models of oxygen-induced retinopathy. , 2003, Frontiers in bioscience : a journal and virtual library.

[31]  A. Vingrys,et al.  The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy , 2010, Documenta Ophthalmologica.

[32]  G. Gao,et al.  Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium-derived Factor , 2002, The Journal of Biological Chemistry.

[33]  S. Ryan,et al.  The development of an experimental model of subretinal neovascularization in disciform macular degeneration. , 1979, Transactions of the American Ophthalmological Society.

[34]  Donald Kennedy,et al.  Breakthrough of the Year , 2007, Science.

[35]  M. Trese,et al.  Identification of novel missense mutations in the Norrie disease gene associated with one X‐linked and four sporadic cases of Familial Exudative Vitreoretinopathy , 1997, Human mutation.

[36]  T. Tahira,et al.  Complexity of the genotype–phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes , 2005, Human mutation.

[37]  B. Klein,et al.  Overview of epidemiologic studies of diabetic retinopathy. , 2007, Ophthalmic epidemiology.

[38]  E. Aguilar,et al.  Three-dimensional in vivo imaging of the mouse intraocular vasculature during development and disease. , 2005, Investigative ophthalmology & visual science.

[39]  P. Campochiaro,et al.  VEGF is major stimulator in model of choroidal neovascularization. , 2000, Investigative ophthalmology & visual science.

[40]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[41]  P. Debré,et al.  CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. , 2007, The Journal of clinical investigation.

[42]  J. Kowalak,et al.  Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.

[43]  J. Holmes,et al.  Incidence and severity of neovascularization in oxygen- and metabolic acidosis-induced retinopathy depend on rat source , 2002, Current Eye Research.

[44]  Marcus Fruttiger,et al.  The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis , 2009, Cell.

[45]  L. Smith,et al.  Characterization of vascular development in the mouse retina. , 1988, Microvascular research.

[46]  Lois E. H. Smith,et al.  Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. , 2003, Pediatrics.

[47]  J. Nathans,et al.  Vascular Development in the Retina and Inner Ear Control by Norrin and Frizzled-4, a High-Affinity Ligand-Receptor Pair , 2004, Cell.

[48]  S. Germain,et al.  Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1–dependent microvascular degeneration , 2005, Nature Medicine.

[49]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor , 1999, Nature Medicine.

[50]  B. Vásárhelyi,et al.  Association of Genetic Polymorphisms of Vascular Endothelial Growth Factor and Risk for Proliferative Retinopathy of Prematurity , 2005, Pediatric Research.

[51]  R. Ali,et al.  Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1 , 2002, Gene Therapy.

[52]  G. Noronha,et al.  Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. , 2008, The Journal of clinical investigation.

[53]  Andreas Stahl,et al.  Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis , 2009, Nature Protocols.

[54]  T. Curtis,et al.  Rod photoreceptor loss in Rho-/- mice reduces retinal hypoxia and hypoxia-regulated gene expression. , 2006, Investigative ophthalmology & visual science.

[55]  M. Boulton,et al.  Insulin-Like Growth Factor Binding Protein-3 Mediates Vascular Repair by Enhancing Nitric Oxide Generation , 2009, Circulation research.

[56]  M. Hartnett,et al.  Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. , 2008, Investigative ophthalmology & visual science.

[57]  R. J. Ross,et al.  A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. , 2009, The American journal of pathology.

[58]  H. Hammes,et al.  Decreased Hypoxia-Induced Neovascularization in Angiopoietin-2 Heterozygous Knockout Mouse through Reduced MMP Activity , 2009, Cellular Physiology and Biochemistry.

[59]  J. Stone,et al.  Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. , 1996, Investigative ophthalmology & visual science.

[60]  P. Campochiaro,et al.  Angiopoietin‐2 plays an important role in retinal angiogenesis , 2002, Journal of cellular physiology.

[61]  K. Csaky,et al.  Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[62]  Martin Friedlander,et al.  Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. , 2002, Investigative ophthalmology & visual science.

[63]  N. Sengupta,et al.  Hematopoietic stem cells provide repair functions after laser-induced Bruch's membrane rupture model of choroidal neovascularization. , 2006, The American journal of pathology.

[64]  P. Campochiaro,et al.  Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.

[65]  R. Higgins,et al.  Dexamethasone alters TNF-alpha expression in retinopathy. , 2001, Molecular genetics and metabolism.

[66]  Lois E. H. Smith,et al.  Emerging Treatments for Retinopathy of Prematurity , 2009, Seminars in ophthalmology.

[67]  Timothy S Kern,et al.  Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. , 2009, Frontiers in bioscience.

[68]  Lois E. H. Smith,et al.  Erythropoietin deficiency decreases vascular stability in mice. , 2008, The Journal of clinical investigation.

[69]  D. Chen,et al.  Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. , 2005, Investigative ophthalmology & visual science.

[70]  Michael I Dorrell,et al.  Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis , 2007, Proceedings of the National Academy of Sciences.

[71]  Andrew P. McMahon,et al.  WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature , 2005, Nature.

[72]  James D. Akula,et al.  Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. , 2007, Investigative ophthalmology & visual science.

[73]  R. Linsenmeier,et al.  Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. , 2000, Investigative ophthalmology & visual science.

[74]  C. Lange,et al.  Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[75]  P. Campochiaro,et al.  Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. , 2000, The American journal of pathology.

[76]  M. Maia,et al.  Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[77]  D B Schaffer,et al.  Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. , 1993, Ophthalmology.

[78]  P. Carmeliet,et al.  Oxygen-Induced Retinopathy in Mice: Amplification by Neonatal IGF-I Deficit and Attenuation by IGF-I Administration , 2009, Pediatric Research.

[79]  P. Campochiaro,et al.  Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. , 2002, The American journal of pathology.

[80]  J. Folch,et al.  Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity , 2007 .

[81]  D. Phelps.  Reduced Severity of Oxygen-Induced Retinopathy in Kittens Recovered in 28% Oxygen , 1988, Pediatric Research.

[82]  J. Penn,et al.  Variable oxygen exposure causes preretinal neovascularization in the newborn rat. , 1993, Investigative ophthalmology & visual science.

[83]  M. Repka,et al.  Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP). , 2006, Archives of ophthalmology.

[84]  M. R. Powers,et al.  MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy. , 2008, Investigative ophthalmology & visual science.

[85]  Lois E. H. Smith,et al.  Early Weight Gain Predicts Retinopathy in Preterm Infants: New, Simple, Efficient Approach to Screening , 2009, Pediatrics.

[86]  Holger Gerhardt,et al.  Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis , 2007, Nature.

[87]  H. Hammes,et al.  Incipient Diabetic Retinopathy – Insights from an Experimental Model , 2007, Ophthalmologica.

[88]  J. Flynn,et al.  Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. , 1991, Ophthalmology.

[89]  A. Vingrys,et al.  Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity , 2007, The Journal of comparative neurology.

[90]  Lois E. H. Smith,et al.  Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice. , 2009, Investigative ophthalmology & visual science.

[91]  C. Kahn,et al.  Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. , 2003, The Journal of clinical investigation.

[92]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. , 1996, Archives of ophthalmology.

[93]  S. Mukai,et al.  The Wnt Signaling Pathway in Familial Exudative Vitreoretinopathy and Norrie Disease , 2007, Seminars in ophthalmology.

[94]  M. Naash,et al.  Ambient hypoxia reverses retinal vascular attenuation in a transgenic mouse model of autosomal dominant retinitis pigmentosa. , 2000, Investigative ophthalmology & visual science.

[95]  M. Hartnett,et al.  Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity , 2008, Molecular vision.

[96]  R. Hardy,et al.  The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP). , 2001, Ophthalmology.

[97]  Lois E. H. Smith,et al.  IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth , 2007, Proceedings of the National Academy of Sciences.

[98]  I. Casteels,et al.  Perinatal growth characteristics and associated risk of developing threshold retinopathy of prematurity. , 2003, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[99]  R. Higgins,et al.  Dexamethasone Alters TNF-α Expression in Retinopathy , 2001 .

[100]  Dao-Yi Yu,et al.  Intraretinal oxygen levels before and after photoreceptor loss in the RCS rat. , 2000, Investigative ophthalmology & visual science.

[101]  Martin Friedlander,et al.  T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. , 2006, Investigative ophthalmology & visual science.

[102]  D. Watanabe.  [Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy]. , 2007, Nippon Ganka Gakkai zasshi.

[103]  Michael I Dorrell,et al.  Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. , 2006, The Journal of clinical investigation.

[104]  Lois E. H. Smith,et al.  Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. , 2009, Investigative ophthalmology & visual science.

[105]  Masahiko Watanabe,et al.  Functions of the two glutamate transporters GLAST and GLT-1 in the retina. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[106]  A. Fielder,et al.  A mutation in the Norrie disease gene (NDP) associated with X–linked familial exudative vitreoretinopathy , 1993, Nature genetics.

[107]  D. Rosenbaum,et al.  Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[108]  M. Hayden,et al.  Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy , 2002, Nature Genetics.

[109]  K. Plate,et al.  Vascular endothelial growth factor , 1997, Journal of Neuro-Oncology.

[110]  Lois E. H. Smith,et al.  Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. , 2009, Archives of ophthalmology.

[111]  H. Tanihara,et al.  Elevated erythropoietin in vitreous with ischemic retinal diseases , 2004, Neuroreport.

[112]  Alan W. Stitt,et al.  Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. , 2006, Investigative ophthalmology & visual science.

[113]  M. Repka,et al.  Involution of Retinopathy of Prematurity , 2000 .

[114]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[115]  A. Joussen,et al.  Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. , 2006, Investigative ophthalmology & visual science.

[116]  D. Hinton,et al.  Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization , 2005, Laboratory Investigation.

[117]  P. Campochiaro,et al.  VEGF‐TRAPR1R2 suppresses choroidal neovascularization and VEGF‐induced breakdown of the blood–retinal barrier , 2003 .

[118]  M. C. Leske,et al.  Prevalence of open-angle glaucoma among adults in the United States. , 2004, Archives of ophthalmology.

[119]  G. Yancopoulos,et al.  VEGF-initiated blood-retinal barrier breakdown in early diabetes. , 2001, Investigative ophthalmology & visual science.

[120]  H. Holländer,et al.  Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. , 1992, Investigative ophthalmology & visual science.

[121]  Ying Chen,et al.  Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. , 2005, The American journal of pathology.

[122]  Lois E. H. Smith,et al.  Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.

[123]  Lois E. H. Smith,et al.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[124]  E. Scott,et al.  Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization , 2002, Nature Medicine.

[125]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[126]  P. Campochiaro,et al.  Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. , 1998, Investigative ophthalmology & visual science.

[127]  S. Harper,et al.  Therapeutic potential of manipulating VEGF splice isoforms in oncology. , 2009, Future oncology.

[128]  Rui Bernardes,et al.  Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes , 2005, Progress in Retinal and Eye Research.

[129]  I. Hansen‐Pupp,et al.  New insights into the development of retinopathy of prematurity – importance of early weight gain , 2010, Acta paediatrica.

[130]  P. Carmeliet,et al.  Development of targeted angiogenic medicine , 2009, Journal of thrombosis and haemostasis : JTH.

[131]  K. Costeloe,et al.  Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies? , 1997, The American journal of clinical nutrition.

[132]  M. Bartoli,et al.  Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives , 2003, Diabetes/metabolism research and reviews.

[133]  S. D'Anna,et al.  Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. , 1998, Investigative ophthalmology & visual science.

[134]  P. Campochiaro,et al.  VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. , 2003, Journal of cellular physiology.

[135]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[136]  P. Schimmel,et al.  Bone marrow–derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis , 2002, Nature Medicine.

[137]  P. Hardy,et al.  Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. , 2004, Free radical biology & medicine.

[138]  P. Campochiaro,et al.  Nitric oxide is proangiogenic in the retina and choroid * , 2002, Journal of cellular physiology.

[139]  Lois E. H. Smith,et al.  0013-7227/02/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 87(7):3413–3416 Printed in U.S.A. Copyright © 2002 by The Endocrine Society IGF-I Is Critical for Normal Vascularization of the Human , 2022 .

[140]  Ingeborg Stalmans,et al.  Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. , 2002, The Journal of clinical investigation.

[141]  P. Campochiaro,et al.  Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. , 1997, Histology and histopathology.

[142]  M. C. Leske,et al.  The prevalence of diabetic retinopathy among adults in the United States. , 2004, Archives of ophthalmology.

[143]  R. D'Amato,et al.  Genetic loci that control the size of laser‐induced choroidal neovascularization , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[144]  T. Kern,et al.  Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes , 2007, Diabetologia.

[145]  P. Campochiaro,et al.  Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. , 1999, Investigative ophthalmology & visual science.

[146]  S. Nishikawa,et al.  PDGF Mediates a Neuron–Astrocyte Interaction in the Developing Retina , 1996, Neuron.

[147]  C. Serhan,et al.  Resolvins , 2002, The Journal of experimental medicine.

[148]  J. Stone,et al.  Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[149]  Lois E. H. Smith,et al.  Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[150]  Marcus Fruttiger,et al.  Development of the retinal vasculature , 2007, Angiogenesis.

[151]  Karen W. Miller,et al.  Incidence and Early Course of Retlnonathy of Prematurity , 1991 .

[152]  Justine R. Smith,et al.  CCR3 is a target for age-related macular degeneration diagnosis and therapy , 2009, Nature.

[153]  E. Pierce,et al.  Retinopathy of prematurity: molecular pathology and therapeutic strategies. , 2003, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[154]  N. Sengupta,et al.  IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development , 2007, Proceedings of the National Academy of Sciences.

[155]  E. Agrón,et al.  {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. , 2009, The American journal of clinical nutrition.

[156]  R. Sidman,et al.  An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[157]  J. Nathans,et al.  An essential role for frizzled 5 in mammalian ocular development , 2008, Development.

[158]  D. Cerretti,et al.  Angiopoietin/Tek Interactions Regulate MMP-9 Expression and Retinal Neovascularization , 2003, Laboratory Investigation.

[159]  D. Hinton,et al.  Chan, C.K. et al. Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization. Lab. Invest. 85, 721-733 , 2005 .

[160]  E. Scott,et al.  The role of adult bone marrow-derived stem cells in choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[161]  Dao-Yi Yu,et al.  Proceedings of the Australian Physiological and Pharmacological Society Symposium: Diabetes DIABETIC RETINOPATHY EARLY FUNCTIONAL CHANGES , 2006 .

[162]  Kelly A. Johnson,et al.  Therapeutic Effect of Liposomal Superoxide Dismutase in an Animal Model of Retinopathy of Prematurity , 1997, Neurochemical Research.

[163]  Michael I Dorrell,et al.  Chapter 6. Ocular models of angiogenesis. , 2008, Methods in enzymology.

[164]  Ivana K. Kim,et al.  Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. , 2005, Archives of ophthalmology.

[165]  S. J. Phillips,et al.  Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. , 2000, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[166]  P. Hardy,et al.  New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[167]  G. Thurston,et al.  Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting , 2007, Proceedings of the National Academy of Sciences.

[168]  J. Ambati,et al.  Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[169]  Michael I Dorrell,et al.  Global gene expression analysis of the developing postnatal mouse retina. , 2004, Investigative ophthalmology & visual science.

[170]  J. Stone,et al.  Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. , 1992, Investigative ophthalmology & visual science.

[171]  Lois E. H. Smith,et al.  VITREAL LEVELS OF ERYTHROPOIETIN ARE INCREASED IN PATIENTS WITH RETINAL VEIN OCCLUSION AND CORRELATE WITH VITREAL VEGF AND THE EXTENT OF MACULAR EDEMA , 2010, Retina.

[172]  Lois E. H. Smith,et al.  Transforming growth factor β1 induction of vascular endothelial growth factor receptor 1: Mechanism of pericyte-induced vascular survival in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[173]  R. Sidman,et al.  Spare the rod and spoil the eye , 2005, British Journal of Ophthalmology.

[174]  X. Mu,et al.  The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis , 2008, Nature Medicine.

[175]  G. Siuzdak,et al.  Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen‐induced retinopathy , 2010, Glia.

[176]  A. Otani,et al.  Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina. , 2004, Blood.

[177]  B. Gong,et al.  Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. , 2007, Investigative ophthalmology & visual science.

[178]  J. Provis,et al.  Development of the human retinal vasculature: cellular relations and VEGF expression. , 1997, Experimental eye research.

[179]  J. Sangiovanni,et al.  The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina , 2005, Progress in Retinal and Eye Research.

[180]  John D Lambris,et al.  Drusen complement components C3a and C5a promote choroidal neovascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[181]  Marcus Fruttiger,et al.  Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes , 2005, Development.

[182]  Martin Friedlander,et al.  Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina , 2006, Progress in Retinal and Eye Research.

[183]  A. Stahl,et al.  Computer-aided quantification of retinal neovascularization , 2009, Angiogenesis.

[184]  Y. Courtois,et al.  Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy , 2003, Circulation.

[185]  N. D. Wangsa-Wirawan,et al.  Retinal Oxygen Fundamental and Clinical Aspects , 2003 .

[186]  N. Sengupta,et al.  Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells , 2007, Diabetes.

[187]  S. Pri-chen,et al.  An increase in superoxide dismutase ameliorates oxygen-induced retinopathy in transgenic mice , 2005, Eye.

[188]  P. Schimmel,et al.  A fragment of human TrpRS as a potent antagonist of ocular angiogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[189]  Benita J. O’Colmain,et al.  Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.

[190]  Leh Smith.  Pathogenesis of retinopathy of prematurity , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[191]  D. Phelps,et al.  Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants. , 1999, The Cochrane database of systematic reviews.

[192]  O. Saugstad.  Retinopathy of Prematurity : What Is New ? , 2006 .

[193]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[194]  Lois E. H. Smith,et al.  Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. , 2003, The Journal of clinical investigation.